225 related articles for article (PubMed ID: 30575306)
41. TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia.
Thielemans N; Demeyer S; Mentens N; Gielen O; Provost S; Cools J
Haematologica; 2022 Oct; 107(10):2304-2317. PubMed ID: 35354248
[TBL] [Abstract][Full Text] [Related]
42. Integration of high-resolution methylome and transcriptome analyses to dissect epigenomic changes in childhood acute lymphoblastic leukemia.
Busche S; Ge B; Vidal R; Spinella JF; Saillour V; Richer C; Healy J; Chen SH; Droit A; Sinnett D; Pastinen T
Cancer Res; 2013 Jul; 73(14):4323-36. PubMed ID: 23722552
[TBL] [Abstract][Full Text] [Related]
43. Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma.
Li G; Xu W; Zhang L; Liu T; Jin G; Song J; Wu J; Wang Y; Chen W; Zhang C; Chen X; Ding Z; Zhu P; Zhang B
EBioMedicine; 2019 Sep; 47():128-141. PubMed ID: 31492561
[TBL] [Abstract][Full Text] [Related]
44. DNA methylation pattern is altered in childhood T-cell acute lymphoblastic leukemia patients as compared with normal thymic subsets: insights into CpG island methylator phenotype in T-ALL.
Kraszewska MD; Dawidowska M; Larmonie NS; Kosmalska M; Sędek Ł; Szczepaniak M; Grzeszczak W; Langerak AW; Szczepański T; Witt M;
Leukemia; 2012 Feb; 26(2):367-71. PubMed ID: 21836607
[No Abstract] [Full Text] [Related]
45. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
46. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
[TBL] [Abstract][Full Text] [Related]
47. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
Abe M; Watanabe N; McDonell N; Takato T; Ohira M; Nakagawara A; Ushijima T
Oncology; 2008; 74(1-2):50-60. PubMed ID: 18544995
[TBL] [Abstract][Full Text] [Related]
48. Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers.
An B; Kondo Y; Okamoto Y; Shinjo K; Kanemitsu Y; Komori K; Hirai T; Sawaki A; Tajika M; Nakamura T; Yamao K; Yatabe Y; Fujii M; Murakami H; Osada H; Tani T; Matsuo K; Shen L; Issa JP; Sekido Y
Int J Cancer; 2010 Nov; 127(9):2095-105. PubMed ID: 20131317
[TBL] [Abstract][Full Text] [Related]
49. Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup.
Touzart A; Mayakonda A; Smith C; Hey J; Toth R; Cieslak A; Andrieu GP; Tran Quang C; Latiri M; Ghysdael J; Spicuglia S; Dombret H; Ifrah N; Macintyre E; Lutsik P; Boissel N; Plass C; Asnafi V
Sci Transl Med; 2021 May; 13(595):. PubMed ID: 34039737
[TBL] [Abstract][Full Text] [Related]
50. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome.
Mansur MB; Emerenciano M; Brewer L; Sant'Ana M; Mendonça N; Thuler LC; Koifman S; Pombo-de-Oliveira MS
Leuk Lymphoma; 2009 Aug; 50(8):1318-25. PubMed ID: 19562638
[TBL] [Abstract][Full Text] [Related]
51. Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma.
Koh YW; Chun SM; Park YS; Song JS; Lee GK; Khang SK; Jang SJ
Tumour Biol; 2016 Aug; 37(8):10675-84. PubMed ID: 26867769
[TBL] [Abstract][Full Text] [Related]
52. Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).
Shaw TI; Dong L; Tian L; Qian C; Liu Y; Ju B; High A; Kavdia K; Pagala VR; Shaner B; Pei D; Easton J; Janke LJ; Porter SN; Ma X; Cheng C; Pruett-Miller SM; Choi J; Yu J; Peng J; Gu W; Look AT; Downing JR; Zhang J
Sci Rep; 2021 Mar; 11(1):5154. PubMed ID: 33664368
[TBL] [Abstract][Full Text] [Related]
53. DNA methylome analysis of acute lymphoblastic leukemia cells reveals stochastic de novo DNA methylation in CpG islands.
Wahlberg P; Lundmark A; Nordlund J; Busche S; Raine A; Tandre K; Rönnblom L; Sinnett D; Forestier E; Pastinen T; Lönnerholm G; Syvänen AC
Epigenomics; 2016 Oct; 8(10):1367-1387. PubMed ID: 27552300
[TBL] [Abstract][Full Text] [Related]
54. Pan-cancer analysis reveals presence of pronounced DNA methylation drift in CpG island methylator phenotype clusters.
Karpinski P; Pesz K; Sasiadek MM
Epigenomics; 2017 Nov; 9(11):1341-1352. PubMed ID: 28960094
[TBL] [Abstract][Full Text] [Related]
55. Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia.
Touzart A; Boissel N; Belhocine M; Smith C; Graux C; Latiri M; Lhermitte L; Mathieu EL; Huguet F; Lamant L; Ferrier P; Ifrah N; Macintyre E; Dombret H; Asnafi V; Spicuglia S
Haematologica; 2020 Jun; 105(6):1575-1581. PubMed ID: 31537687
[TBL] [Abstract][Full Text] [Related]
56. Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.
Dai YT; Zhang F; Fang H; Li JF; Lu G; Jiang L; Chen B; Mao DD; Liu YF; Wang J; Peng LJ; Feng C; Chen HF; Mu JX; Zhang QL; Wang H; Ariffin H; Moy TA; Wang JH; Lou YJ; Chen SN; Wang Q; Liu H; Shan Z; Matsumura I; Miyazaki Y; Yasuda T; Dou LP; Yan XJ; Yan JS; Yeoh AE; Wu DP; Kiyoi H; Hayakawa F; Jin J; Wang SY; Sun XJ; Mi JQ; Chen Z; Huang JY; Chen SJ
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2120787119. PubMed ID: 35385357
[TBL] [Abstract][Full Text] [Related]
57. Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.
Arai E; Gotoh M; Tian Y; Sakamoto H; Ono M; Matsuda A; Takahashi Y; Miyata S; Totsuka H; Chiku S; Komiyama M; Fujimoto H; Matsumoto K; Yamada T; Yoshida T; Kanai Y
Int J Cancer; 2015 Dec; 137(11):2589-606. PubMed ID: 26061684
[TBL] [Abstract][Full Text] [Related]
58. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
59. TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Tan SH; Tan TK; Yokomori R; Liao M; Huang XZ; Yeoh AEJ; Sanda T
Leukemia; 2023 Oct; 37(10):1969-1981. PubMed ID: 37591943
[TBL] [Abstract][Full Text] [Related]
60. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.
Milani L; Lundmark A; Kiialainen A; Nordlund J; Flaegstad T; Forestier E; Heyman M; Jonmundsson G; Kanerva J; Schmiegelow K; Söderhäll S; Gustafsson MG; Lönnerholm G; Syvänen AC
Blood; 2010 Feb; 115(6):1214-25. PubMed ID: 19965625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
